Lorundrostat 25mg+SGLT2i QD, Washout, Placebo+SGLT2i QD
3 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Lorundrostat 25mg+SGLT2i QD, Washout, Placebo+SGLT2i QD for albuminuria | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Lorundrostat 25mg+SGLT2i QD, Washout, Placebo+SGLT2i QD for hypertension | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Lorundrostat 25mg+SGLT2i QD, Washout, Placebo+SGLT2i QD for renal insufficiency, chronic | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |